Jan 20 (Reuters) - Isomorphic Labs, which uses artificial intelligence for drug discovery, expects to have its first clinical trials by the end of 2026, founder and CEO Demis Hassabis said on Tuesday.

Add Yahoo as a preferred source to see more of our stories on Google. Demis Hassabis speaks during the 56th annual World Economic Forum (WEF) meeting in Davos, Switzerland, January 20, 2026.

In 2024, we saw games where soldiers dove headfirst into alien planets to defend Earth, Princess Zelda led her very own legend, a little robot overcame impossible odds to rescue PlayStation’s greatest ...

The Democratic National Committee (DNC) has decided against releasing its postmortem of the party’s 2024 losses it looks to build on 2025 momentum and take back power in Congress during next year’s ...

According to @demishassabis on Bloomberg Tech Europe, Isomorphic Labs is leveraging artificial intelligence to design new drug candidates that address challenging medical targets. The discussion with ...

JavaScript’s low bar to entry has resulted in one of the richest programming language ecosystems in the world. This month’s report celebrates the bounty, while also highlighting a recent example of ...

For the most part, 2024 was a solid year for isekai anime, with each season including at least a couple of good shows. While newcomers like Demon Lord 2099 and The Wrong Way To Use Healing Magic ...

React conquered XSS? Think again. That's the reality facing JavaScript developers in 2025, where attackers have quietly evolved their injection techniques to exploit everything from prototype ...

Alphabet’s Isomorphic Labs is preparing to launch human trials of AI-designed drugs, its president, Colin Murdoch, told Fortune. Born from DeepMind’s AlphaFold breakthrough, the company is pairing ...

Isomorphic Labs, the AI-powered drug company spun out of Google’s DeepMind, just announced that it’s “getting ready” to begin human clinical trials of drugs designed by AI. The news comes as tech ...

Add Yahoo as a preferred source to see more of our stories on Google. In April 2025, Isomorphic Labs raised a $600 million in its first-ever external funding round, led by Thrive Capital. Alphabet’s ...